MENU
CRNX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Crinetics Pharmaceuticals (CRNX) Ownership - Who owns Crinetics Pharmaceuticals?
Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors... Show more
Industry: #Pharmaceuticals Major
Profile
Industry
Pharmaceuticals Major
Address
6055 Lusk Boulevard
Phone
+1 858 450-6464
Employees
290
Web
https://www.crinetics.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
2.61B
P/E Ratio
N/A
Total Cash
1.27B
Projected Growth
N/A
Total Debt
50.82M
Revenue
760K
Risk (Beta)
-0.58
Dividend Yield
N/A
Total Cash/Share
13.60
Total Debt/Equity
N/A
Revenue/Share
0.01 USD as % of share price
Fundamentals
CRNX
Capitalization
2.61B
P/E Ratio
N/A
Risk (Beta)
-0.58
Dividend Yield
N/A
Total Cash
1.27B
Total Cash/Share
13.60
Total Debt
50.8M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.01%
Revenue
760K
ROE
N/A
Book Value
1.25B
P/B Ratio
2.08
Cash Flow
N/A
Earnings
-3.8
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
2.3B
Current Ratio
22.53
Current Revenue Per Employee
826.09
Dividends Per Share - Security
N/A
EBITDA
-373.49M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-28.06
Shares Held By Institutions
5.47B
Shares Outstanding - Current
93.7M
Total Liabilities
107M
Total Volume MTD
N/A
Value
-1
Gain YTD
-45.551
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a developer of therapeutics for endocrine-related diseases
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
6055 Lusk Boulevard
Phone
+1 858 450-6464
Employees
290
Web
https://www.crinetics.com